Mixed
Multiplatform metabolomics profiling of fasting blood samples can identify specific metabolic signatures—including elevated branched-chain amino acids, ketone bodies, and altered lipid ratios, alongside decreased 1,5-anhydroglucitol—that distinguish individuals with type 2 diabetes from healthy controls, even under sub-clinical conditions.
For individuals concerned about diabetes risk, this research suggests that looking beyond standard blood sugar tests to a broader metabolic profile (including fats, amino acids, and gut-related metabolites) may offer earlier detection of metabolic dysfunction. This approach could help identify those at high risk for complications before clinical symptoms appear, enabling more personalized monitoring and prevention strategies.
Our study depicts the promising potential of metabolomics in diabetes research by identification of a series of known and also novel, deregulated metabolites that associate with diabetes. Key observations include perturbations of metabolic pathways linked to kidney dysfunction (3-indoxyl sulfate), lipid metabolism (glycerophospholipids, free fatty acids), and interaction with the gut microflora (bile acids).
Why this rating
The study uses a rigorous multiplatform approach (NMR, MS) on a defined epidemiological cohort, but the sample size (n=100) is small for broad generalization, and it is a cross-sectional observational study rather than an intervention.
Source
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting
Karsten Suhre et al. · PLoS ONE · 2010
DOI 10.1371/journal.pone.0013953
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →